Capital One Series J Preferred Stock
COF.PRJ
6 hedge funds and large institutions have $1.36M invested in Capital One Series J Preferred Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
505% more capital inflows, than outflows
Capital inflows: $355K | Capital outflows: $58.6K
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0.03% more ownership
Funds ownership: 0.12% → 0.15% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OP
ORG Partners
Roanoke,
Indiana
|
+$354K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Roanoke Asset Management
Jersey City,
New Jersey
|
-$58.6K |
COF.PRJ Hedge Fund Activity: Q4 2024 in Review
6 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Capital One Series J Preferred Stock (COF.PRJ) for Q4 2024, worth a combined $1.36M — up 14% from $1.2M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new COF.PRJ positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was ORG Partners, adding an estimated $354K. The largest seller was Roanoke Asset Management, cutting an estimated $58.6K.
- 6 institutional investors held Capital One Series J Preferred Stock (COF.PRJ) as of Q4 2024, up from 5 in Q3 2024.
- Funds reported $1.36M of Capital One Series J Preferred Stock stock for Q4 2024, up 14% quarter-over-quarter.
- 1 fund opened new Capital One Series J Preferred Stock positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest Capital One Series J Preferred Stock buyer in Q4 2024 was ORG Partners, an estimated $354K added.
- The largest Capital One Series J Preferred Stock seller in Q4 2024 was Roanoke Asset Management, an estimated $58.6K sold.
Based on aggregated 13F filings for Q4 2024.